Reduction of Recurrent Stroke in Patients with Patent Foramen Ovale (PFO)

Trial ID:
Matthew J Price, M.D.
This study will look at closing the PFO to reduce the risk of another stroke using a commercial market-approved medical device called a septal occluder.

Inclusion Criteria

Patients must:

  • Be 18-70 years of age
    Have been diagnosed with an ischemic stroke within the last 455 days
    Have the presence of a PFO
    Be willing and able to comply with protocol requirements, including follow-up visits

Exclusion Criteria

Patients must not:

  • Have a history of, or ongoing, atrial fibrillation/flutter
    Have had a previous heart attack

Additional Info

All treatments and physician visits during this study will take place at Scripps Memorial Hospital, Anderson Medical Pavilion in La Jolla.

Search for NCT03821129 at for more information.

Study participation will last up to 5 years.

Contact Info:

  • Clinical Research Services